Drug Side Effects
Search
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT
was reported 26 times
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Histone Deacetylase Inhibitor [EPC]
2
0.0005
1
Topoisomerase Inhibitor [EPC]
9
0.0001
2
CD52-directed Cytolytic Antibody [EPC]
2
0.0001
3
CD30-directed Immunoconjugate [EPC]
1
0.0001
4
Alkylating Drug [EPC]
16
0.0001
5
Calcineurin Inhibitor Immunosuppressant [EPC]
2
0.0000
6
Corticosteroid [EPC]
18
0.0000
7
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
8
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
9
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
10
Platinum-based Drug [EPC]
2
0.0000
11
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
12
Leukocyte Growth Factor [EPC]
1
0.0000
13
Azole Antifungal [EPC]
1
0.0000
14
Janus Kinase Inhibitor [EPC]
1
0.0000
15
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
16
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
17
Thiazide Diuretic [EPC]
1
0.0000
18
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
19
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
20
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
21
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
22
Insulin Analog [EPC]
1
0.0000
23
Thalidomide Analog [EPC]
1
0.0000
24
Kinase Inhibitor [EPC]
1
0.0000